These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 32106996)
21. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome. Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320 [TBL] [Abstract][Full Text] [Related]
22. Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: correlation with basal FSH and LH levels and LH/FSH ratio: a cross-sectional study. Racoubian E; Aimagambetova G; Finan RR; Almawi WY BMC Womens Health; 2020 Jun; 20(1):134. PubMed ID: 32586307 [TBL] [Abstract][Full Text] [Related]
23. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome. Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312 [TBL] [Abstract][Full Text] [Related]
24. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495 [TBL] [Abstract][Full Text] [Related]
25. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome. Chun S Clin Exp Reprod Med; 2014 Jun; 41(2):86-91. PubMed ID: 25045633 [TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726 [TBL] [Abstract][Full Text] [Related]
27. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579 [TBL] [Abstract][Full Text] [Related]
28. Serum reproductive hormone levels and ultrasound findings in female offspring after intracytoplasmic sperm injection: first results. Belva F; Roelants M; Vloeberghs V; Schiettecatte J; Evenepoel J; Bonduelle M; de Vos M Fertil Steril; 2017 Apr; 107(4):934-939. PubMed ID: 28292621 [TBL] [Abstract][Full Text] [Related]
29. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate. Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732 [TBL] [Abstract][Full Text] [Related]
30. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
31. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Singer T; Barad DH; Weghofer A; Gleicher N Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223 [TBL] [Abstract][Full Text] [Related]
32. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615 [TBL] [Abstract][Full Text] [Related]
33. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Elgindy EA; El-Haieg DO; El-Sebaey A Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520 [TBL] [Abstract][Full Text] [Related]
34. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. Lunsford AJ; Whelan K; McCormick K; McLaren JF Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876 [TBL] [Abstract][Full Text] [Related]
35. Laparoscopic ovarian tissue harvesting for cryopreservation from a child with galactosemia. Vash-Margita A; Szymanska-Vandendriessche K; Gunther K; Rodriguez-Buritica DF; Christison-Lagay E; Saluja S; Oktay KH Fertil Steril; 2022 Nov; 118(5):982-984. PubMed ID: 36154768 [TBL] [Abstract][Full Text] [Related]
36. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer]. He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775 [TBL] [Abstract][Full Text] [Related]
37. Antimüllerian hormone, antral follicle count and ovarian volume predict menstrual cycle length in healthy women. Zhu R; Lee BH; Huang Z; Indran IR; Li J; Shen L; Kramer MS; Yong EL Clin Endocrinol (Oxf); 2016 Jun; 84(6):870-7. PubMed ID: 26608631 [TBL] [Abstract][Full Text] [Related]
38. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706 [TBL] [Abstract][Full Text] [Related]
39. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome. van der Westhuizen S; van der Spuy ZM Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098 [TBL] [Abstract][Full Text] [Related]
40. Serum LH levels are associated to serum insulin and Anti-Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology. Makolle S; Catteau-Jonard S; Robin G; Dewailly D Clin Endocrinol (Oxf); 2023 Jul; 99(1):73-78. PubMed ID: 36912207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]